BioLife Solutions, Inc. (BLFS)
34.95
+0.03
(+0.09%)
USD |
NASDAQ |
Sep 11, 16:00
34.93
-0.02
(-0.06%)
After-Hours: 20:00
BioLife Solutions Enterprise Value : 1.642B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.642B |
| September 10, 2026 | 1.641B |
| September 09, 2026 | 1.641B |
| September 08, 2026 | 1.663B |
| September 04, 2026 | 1.657B |
| September 03, 2026 | 1.670B |
| September 02, 2026 | 1.689B |
| September 01, 2026 | 1.667B |
| August 31, 2026 | 1.746B |
| August 28, 2026 | 1.712B |
| August 27, 2026 | 1.752B |
| August 26, 2026 | 1.742B |
| August 25, 2026 | 1.753B |
| August 24, 2026 | 1.752B |
| August 21, 2026 | 1.747B |
| August 20, 2026 | 1.741B |
| August 19, 2026 | 1.716B |
| August 18, 2026 | 1.642B |
| August 17, 2026 | 1.666B |
| August 14, 2026 | 1.648B |
| August 13, 2026 | 1.656B |
| August 12, 2026 | 1.643B |
| August 11, 2026 | 1.636B |
| August 10, 2026 | 1.627B |
| August 07, 2026 | 1.628B |
| Date | Value |
|---|---|
| August 06, 2026 | 1.592B |
| August 05, 2026 | 1.586B |
| August 04, 2026 | 1.523B |
| August 03, 2026 | 1.505B |
| July 31, 2026 | 1.463B |
| July 30, 2026 | 1.480B |
| July 29, 2026 | 1.473B |
| July 28, 2026 | 1.497B |
| July 27, 2026 | 1.390B |
| July 24, 2026 | 1.399B |
| July 23, 2026 | 1.438B |
| July 22, 2026 | 1.456B |
| July 21, 2026 | 1.360B |
| July 20, 2026 | 1.356B |
| July 17, 2026 | 1.358B |
| July 16, 2026 | 1.413B |
| July 15, 2026 | 1.358B |
| July 14, 2026 | 1.334B |
| July 13, 2026 | 1.307B |
| July 10, 2026 | 1.311B |
| July 09, 2026 | 1.313B |
| July 08, 2026 | 1.263B |
| July 07, 2026 | 1.299B |
| July 06, 2026 | 1.292B |
| July 02, 2026 | 1.308B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Repligen Corp. | 9.201B |
| Agilent Technologies, Inc. | 43.62B |
| Danaher Corp. | 164.20B |
| Thermo Fisher Scientific, Inc. | 264.08B |
| West Pharmaceutical Services, Inc. | 24.26B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 45.10M |
| Revenue (Quarterly) | 28.47M |
| Total Expenses (Quarterly) | -16.64M |
| EPS Diluted (Quarterly) | 0.915 |
| Gross Profit Margin (Quarterly) | 63.69% |
| Earnings Yield | 2.77% |
| Operating Earnings Yield | 0.17% |
| Normalized Earnings Yield | 2.767 |